Description:

Study Drug Therapy Form for Protocol #010--PR1003 Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF9311DF-A3A4-2D7C-E034-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=FF9311DF-A3A4-2D7C-E034-0003BA3F9857

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 8/9/14
  3. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

AIDS-Related Lymphoma NCT00310128 Treatment - Study Drug Therapy Form for Protocol #010--PR1003 - 2399688v3.0

No Instruction available.

  1. StudyEvent: Study Drug Therapy Form for Protocol #010--PR1003
    1. No Instruction available.
General info
cm
kg
m2
Initial Prescribed Dose Of Study Drug
Enter Total Dose Of Study Drug Received This Cycle And Dose Modification Codes